How should we plan the future of nanomedicine for cancer diagnosis and therapy?
Author:
Publisher
Elsevier BV
Subject
Pharmaceutical Science
Reference19 articles.
1. First-in-human study testing a new radioenhancer using nanoparticles (NBTXR3) activated by radiation therapy in patients with locally advanced soft tissue sarcomas;Bonvalot;Clin. Cancer Res.,2017
2. Breakthrough discoveries in drug delivery technologies: the next 30 years;Brambilla;J. Control. Release,2014
3. Targeting cancer with hyaluronic acid-based nanocarriers: recent advances and translational perspectives;Cadete;Nanomedicine,2016
4. A holistic approach to targeting disease with polymeric nanoparticles;Cheng;Nat. Rev. Drug Discov.,2015
5. Nanoparticles in drug delivery: past, present and future;Couvreur;Adv. Drug Deliv. Rev.,2013
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Nanotechnological approaches for the treatment of placental dysfunction: recent trends and future perspectives;Nanomedicine;2023-11-22
2. Placental Models for Evaluation of Nanocarriers as Drug Delivery Systems for Pregnancy Associated Disorders;Biomedicines;2022-04-19
3. Contribution of Nanotechnologies to Vaccine Development and Drug Delivery against Respiratory Viruses;PPAR Research;2021-10-27
4. Insights on the polypyrrole based nanoformulations for photodynamic therapy;Journal of Porphyrins and Phthalocyanines;2021-06-26
5. Understanding Nanomedicine Size and Biological Response Dependency: What Is the Relevance of Previous Relationships Established on Only Batch-Mode DLS-Measured Sizes?;Pharmaceutical Research;2020-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3